Zhibing Zheng
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 07, 2026
Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer Immunotherapy.Yalei Wang, Zhenze Qi, Shiyang Sun
|Mar 20, 2026
Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid Tumors.Tingting Yang, Ting Wei, Shiyang Sun
|Aug 01, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological Cancers.Ting Wei, Shiyang Sun, Xiaotong Hu
|Jul 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of Cancers.Changkai Jia, Pengli Wei, Shiyang Sun
|Oct 24, 2023
The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders.Pengyun Li, Bingkun Li, Ning Yang
|Sep 21, 2022
Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.Pengyun Li, Qiaohong Lin, Shiyang Sun
Pageof 1
